Recent years have experienced notable healthcare advancements starting from ?treatment? to ?wellness?. Not only early diagnosis but also an effective treatment of the diseases has also become exceptionally crucial to beat rising cases of viral contagion, their ramification, and reducing mortality rate. Market insights on life science reagents concluded that these reagents are competing for the development of new analytical instruments to curtail diagnosis time and to provide analysis at the initial stage of different ailments. The patients have the liberty to choose the diagnostic center of their choice. It leads to an increased number of point-of-care diagnostic centers compared to laboratory-based diagnostics